18Nov 2019

AMELIORATIVE EFFECT OF CURCUMIN AGAINST HEPATORENAL ADVERSE EFFECTS OF CEFEPIME IN RATS

  • Department of Pharmacology, Faculty of Veterinary Medicine, Moshtohor, Toukh, Elqaliobiya, Egypt
  • Department of Pharmacology, Animal Health Research Institute Benha branch, Benha, Egypt
  • Pharmacist at Benha University Hospital, Benha, Egypt
Crossref Cited-by Linking logo

  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Background: To examine the ameliorative effect of curcumin against the hepatorenal adverse effects of cefepime in rats. Methods: A total of 48 albino rats were divided into four groups, each of 12 rats. Group one was considered as a control and was administered saline solution. Group two was the cefepime-treated group (45 mg/b.wt. intramuscularly) once daily for five consecutive days. Group three was the curcumin-treated group (200 mg/b.wt. orally) once daily for five consecutive and group four was pretreated with curcumin followed by cefepime once daily for five consecutive days as above. Blood samples and liver and kidneys specimens were collected on the first, 7th and 14th day post treatment for serum biochemical assessment and histopathological examinations. Results: Cefepime-treated rats showed significant (P≤0.05) increases in serum levels of aspartate aminotransferase, alanine aminotransferase, total bilirubin, total protein and albumin suggesting liver damage. There were also significant (P≤0.05) increases in the serum levels of urea and creatinine suggesting alterations of kidney functions. The alterations in serum biochemical parameters were associated with histopathological changes in liver and kidney. These alterations could successfully be ameliorated by pretreatment with curcumin. Conclusion: Results suggest a possible contribution of cefepime in hepatic and nephrotoxicity with apparent biochemical and histopathological alterations. Therefore, patient renal function and liver function should be monitored before and during cefepime therapy. Pretreatment with curcumin could limit the adverse effect of cefepime on liver and kidneys.

  1. Elsayed MGA, Elkomy AAA, Elbadawy M. Some Pharmacodynamic Aspects of Cefepime. Journal of Pharmaceutics. 2013;2013:10.
  2. Yahav D, Paul M, Fraser A, Sarid N, Leibovici L. Efficacy and safety of cefepime: a systematic review and meta-analysis. The Lancet Infectious diseases. 2007;7(5):338-348.
  3. Angelescu M, Apostol A. [Cefepime (maxipime), large spectrum 4th generation cephalosporin, resistant to beta-lactamases]. Chirurgia (Bucharest, Romania : 1990). 2001;96(6):547-552.
  4. Chapman TM, Perry CM. Cefepime: a review of its use in the management of hospitalized patients with pneumonia. American journal of respiratory medicine : drugs, devices, and other interventions. 2003;2(1):75-107.
  5. Elsayed MGA, Elkomy AAA, Gaballah MS, Elbadawy M. Nephrotoxicity of cefepime: A new cephalosporin antibiotic in rats. J Pharmacol Pharmacother. 2014;5(1):33-38.
  6. Liao P-F, Wu Y-K, Huang K-L, Chen H-Y. A rare case of cefepime-induced cholestatic liver injury. Ci Ji Yi Xue Za Zhi. 2019;31(2):124-128.
  7. Cekmen M, Ilbey Y, Ozbek E, Simsek A, Somay A, Ersoz C. Curcumin prevents oxidative renal damage induced by acetaminophen in rats. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association. 2009;47:1480-1484.
  8. Kheradpezhouh E, Panjehshahin M-R, Miri R, et al. Curcumin protects rats against acetaminophen-induced hepatorenal damages and shows synergistic activity with N-acetyl cysteine. European Journal of Pharmacology. 2010;628(1):274-281.
  9. Lee HY, Kim SW, Lee GH, et al. Turmeric extract and its active compound, curcumin, protect against chronic CCl4-induced liver damage by enhancing antioxidation. BMC complementary and alternative medicine. 2016;16(1):316.
  10. Lee G-H, Lee H-Y, Choi M-K, Chung H-W, Kim S-W, Chae H-J. Protective effect of Curcuma longa L. extract on CCl(4)-induced acute hepatic stress. BMC Res Notes. 2017;10(1):77-77.
  11. Hosseini A, Hosseinzadeh H. Antidotal or protective effects of Curcuma longa (turmeric) and its active ingredient, curcumin, against natural and chemical toxicities: A review. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2018;99:411-421.
  12. El-Agamy DS. Comparative effects of curcumin and resveratrol on aflatoxin B(1)-induced liver injury in rats. Archives of toxicology. 2010;84(5):389-396.
  13. Reitman S, Frankel S. A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. American journal of clinical pathology. 1957;28(1):56-63.
  14. Tietz NW, Burtis CA, Duncan P, et al. A reference method for measurement of alkaline phosphatase activity in human serum. Clinical chemistry. 1983;29(5):751-761.
  15. Schmidt M, Eisenburg J. [Serum bilirubin determination in newborn infants. A new micromethod for the determination of serum of plasma bilirubin in newborn infants]. Fortschritte der Medizin. 1975;93(30):1461-1466.
  16. Chow BF. The determination of plasma or serum albumin by means of a precipitin reaction. The Journal of biological chemistry. 1947;167(3):757-763.
  17. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. The Journal of biological chemistry. 1951;193(1):265-275.
  18. Larsen K. Creatinine assay by a reaction-kinetic principle. Clinica Chimica Acta. 1972;41:209-217.
  19. Cohn C. Serum Urea Concentrations. JAMA. 1966;196(5):445-445.
  20. Bancroft JD, Layton C. 10 - The hematoxylins and eosin. In: Suvarna SK, Layton C, Bancroft JD, eds. Bancroft's Theory and Practice of Histological Techniques (Eighth Edition). Content Repository Only!; 2019:126-138.
  21. Snedecor G, Cochran W. Statistical methods. 8th ed. Ames, Iowa, USA: Iowa University Press; 1989.
  22. Duncan DB. Multiple Range and Multiple F Tests. Biometrics. 1955;11(1):1-42.
  23. Abe S. A case of ceftriaxone-associated biliary pseudolithiasis in an elderly patient with renal dysfunction. IDCases. 2017;9:62-64.
  24. Haboob A. Cefixime-induced hepatotoxicity and acute renal failure: a case report. European Journal of Medical Case Reports. 2018:1.
  25. Bjornsson ES. Drug-induced liver injury due to antibiotics. Scandinavian journal of gastroenterology. 2017;52(6-7):617-623.
  26. Mujeeb M, Jalikar K. Pharmacokinetic study of cefpirome: fourth generation cephalosporin. Journal of Evolution of Medical and Dental Sciences. 2015;4:11834-11840.
  27. Biner B, Oner N, Celtik C, et al. Ceftriaxone-associated biliary pseudolithiasis in children. Journal of clinical ultrasound : JCU. 2006;34(5):217-222.
  28. Bartkowska-Sniatkowska A, Jonczyk-Potoczna K, Zielinska M, Rosada-Kurasinska J. Adverse reaction to ceftriaxone in a 28-day-old infant undergoing urgent craniotomy due to epidural hematoma: review of neonatal biliary pseudolithiasis. Therapeutics and clinical risk management. 2015;11:1035-1041.
  29. El-Sayed MGA, Elkomy AA, Aboubakr M. Hepatotoxic Evaluation in Albino Rats Exposed to Ceftriaxone. Asian J Pharm Biol Res 2011;1:145-150.
  30. El-Safty Z, Elsayed M, Elbadawy M. hepato-renal adverse effects of amoxicilllin and doxycycline in rats. World J Pharm Pharm Sci. 2018;7(2):1-12.
  31. Qadri I, Zeng X, Guo R, Koratala A. Acute interstitial nephritis and DRESS syndrome without eosinophilia associated with cefepime. BMJ case reports. 2017;2017.
  32. Joob B, Wiwanitkit V. Oral cefepime-induced sterile pyuria and impaired renal function. Annals of Tropical Medicine and Public Health. 2016;9(6):419-420.
  33. Soliman AM. Hepato-renal effects of cefotaxime in albino rats. 2015;7:312-315.
  34. Jiang M, Yao J, Zhang LI, et al. Comparison of the influence on renal function between cefepime and cefpirome. Biomed Rep. 2016;4(1):40-44.
  35. Abou-Samra S, El Ashmawy I, EL-Sawy A. Effects of Cefepime on Male Rats. Alex J Vet Science. 2012;37(1):55-69.
  36. Mac K, Chavada R, Paull S, Howlin K, Wong J. Cefepime induced acute interstitial nephritis--a case report. BMC Nephrol. 2015;16:15-15.
  37. El Maddawy K, Bogzil A. Adverse effects of cefotaxime sodium in comparison with ceftiofur sodium in male rats. International Journal of Pharmacy & Life Sciences. 2015;6(3):4291-4303.
  38. A E-S, A E-K, Abd Al-Wahed A. Protective Effect of Curcumin Against Adverse Effects of Meloxicam in Rats. Benha Veterinary Medical Journal. 2017;33(2):58-64.
  39. Poapolathep S, Imsilp K, Machii K, Kumagai S, Poapolathep A. The Effects of Curcumin on Aflatoxin B1- Induced Toxicity in Rats. Biocontrol science. 2015;20(3):171-177.
  40. Azab A, Fetouh F, Albasha M. Nephro-protective effects of curcumin, rosemary and propolis against gentamicin induced toxicity in guinea pigs: Morphological and biochemical study. American Journal of Clinical and Experimental Medicine. 2014;2:28-35.
  41. Manjunatha H, Srinivasan K. Protective effect of dietary curcumin and capsaicin on induced oxidation of low-density lipoprotein, iron-induced hepatotoxicity and carrageenan-induced inflammation in experimental rats. The FEBS journal. 2006;273(19):4528-4537.
  42. Bao W, Li K, Rong S, et al. Curcumin alleviates ethanol-induced hepatocytes oxidative damage involving heme oxygenase-1 induction. Journal of ethnopharmacology. 2010;128(2):549-553.
  43. Ahmad MM, Rezk NA, Fawzy A, Sabry M. Protective effects of curcumin and silymarin against paracetamol induced hepatotoxicity in adult male albino rats. Gene. 2019;712:143966.
  44. Ismail A, Salem A. Renoprotective effect of curcumin on acetaminophen-induced nephrotoxicity in rats. 2016;8:773-779.
  45. Ali BH, Al-Wabel N, Mahmoud O, Mousa HM, Hashad M. Curcumin has a palliative action on gentamicin-induced nephrotoxicity in rats. Fundamental & clinical pharmacology. 2005;19(4):473-477.
  46. Mohajeri M, Sahebkar A. Protective effects of curcumin against doxorubicin-induced toxicity and resistance: A review. Critical reviews in oncology/hematology. 2018;122:30-51.
  47. Shaterpour M, Shaki F, Ghasemi M, Jafari-Sabet M, Ziar A, Ataee R. The protective effect of curcumin against lithium-induced nephrotoxicity in rats. mazums-pbr. 2017;3(2):33-38.

[Mossad G.A. Elsayed, Enas A.H. Farag, Hala E.M. Abo Elfetouh (2019); AMELIORATIVE EFFECT OF CURCUMIN AGAINST HEPATORENAL ADVERSE EFFECTS OF CEFEPIME IN RATS Int. J. of Adv. Res. 7 (Nov). 1005-1012] (ISSN 2320-5407). www.journalijar.com

Hala E.M. Abo Elfetouh
Pharmacist at Benha University Hospital, Benha, Egypt.

DOI:

Article DOI: 10.21474/IJAR01/10106      
DOI URL: https://dx.doi.org/10.21474/IJAR01/10106

Download Full Paper

Download PDF No. of Downloads: 15 | No. of Views: 66